Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1062902.RAdka3WSPt9y6H44D50T1nKPYjeOijuXCJUS4CwTzhbDg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1062902.RAdka3WSPt9y6H44D50T1nKPYjeOijuXCJUS4CwTzhbDg130_assertion type Assertion NP1062902.RAdka3WSPt9y6H44D50T1nKPYjeOijuXCJUS4CwTzhbDg130_head.
- NP1062902.RAdka3WSPt9y6H44D50T1nKPYjeOijuXCJUS4CwTzhbDg130_assertion description "[FAS surface expression on DN T cells should be assessed routinely and FAS haploinsufficient patients should be followed as its potential for lymphomagenesis is not well defined and a second hit might occur later on.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1062902.RAdka3WSPt9y6H44D50T1nKPYjeOijuXCJUS4CwTzhbDg130_provenance.
- NP1062902.RAdka3WSPt9y6H44D50T1nKPYjeOijuXCJUS4CwTzhbDg130_assertion evidence source_evidence_literature NP1062902.RAdka3WSPt9y6H44D50T1nKPYjeOijuXCJUS4CwTzhbDg130_provenance.
- NP1062902.RAdka3WSPt9y6H44D50T1nKPYjeOijuXCJUS4CwTzhbDg130_assertion SIO_000772 23524443 NP1062902.RAdka3WSPt9y6H44D50T1nKPYjeOijuXCJUS4CwTzhbDg130_provenance.
- NP1062902.RAdka3WSPt9y6H44D50T1nKPYjeOijuXCJUS4CwTzhbDg130_assertion wasDerivedFrom befree-2016 NP1062902.RAdka3WSPt9y6H44D50T1nKPYjeOijuXCJUS4CwTzhbDg130_provenance.
- NP1062902.RAdka3WSPt9y6H44D50T1nKPYjeOijuXCJUS4CwTzhbDg130_assertion wasGeneratedBy ECO_0000203 NP1062902.RAdka3WSPt9y6H44D50T1nKPYjeOijuXCJUS4CwTzhbDg130_provenance.